University of Vermont

College of Medicine

Department of Surgery

Bio for Thomas P. Ahern, PhD, MPH
Thomas P. Ahern, PhD, MPH

Thomas P. Ahern, PhD, MPH

Assistant Professor
Division of Surgical Research

Assistant Professor
Department of Biochemistry


Contact Information
E-mail: Thomas.Ahern@med.uvm.edu
Office Location:
University of Vermont, 89 Beaumont Avenue, D317A Given Bldg., Burlington, VT, 05405

Education

PhD, Boston University, Boston, MA (2010)
MPH, Boston University, Boston, MA (2006)
BS, University of Vermont, Burlington, VT (1999)

Postdoctoral Training

Post-Doctoral Research Fellow, Cancer Epidemiology, Harvard School of Public Health, Boston, MA (2010-2012)

Academic Appointments

Assistant Professor, Department of Biochemistry, University of Vermont, Burlington, VT (2014-Present)
Assistant Professor, Department of Surgery, College of Medicine, University of Vermont, Burlington, VT (2013-Present)

Other Professional Appointments

Instructor, Department of Medicine, Harvard Medical School, Boston, MA (2011-2012)
Visiting Fellow, Department of Clinical Epidemiology, Aarhus University, Denmark
(2012-2013) 
Associate Epidemiologist, Channing Division of Network Medicine, Department of Medicine, Brigham and Women’s Hospital, Boston, MA (2012-2013)

Awards and Honors

Scholar-in-Training Award, Molecular Epidemiology Working Group, American Association for Cancer Research (2012)
Clinical Research Student Loan Repayment Program, National Institutes of Health (2012)
Fred F. Kadlubar Memorial Scholar-in-Training Award, American Association for Cancer Research (2011)
Best Presentation by a Post-Doctoral Fellow, Harvard School of Public Health (2011) 

Publications

Ahern TP, Cronin-Fenton DP, Lash TL, Sørensen HT, Ording AG, Hamilton-Dutoit SJ, Hellberg Y.  Pak1, adjuvant tamoxifen therapy, and breast cancer recurrence risk in a Danish population-based study.  Acta Oncol.  2016 Apr 8:1-8. [Epub ahead of print].   PMID: 27056567

Ahern TP, Horváth-Puhó E, Spindler KL, Sørensen HT, Ording AG, Erichsen R.  Colorectal cancer, comorbidity, and risk of venous thromboembolism: assessment of biological interactions in a Danish nationwide cohort.  Br J Cancer.  2016 Jan 12;114(1):96-102.  doi: 10.1038/bjc.2015.406.  Epub 2015 Dec 1.  PMID: 26625005.  PMCID: PMC4716535.  [Available on 2017-01-12]

Cronin-Fenton DP, Heide-Jørgensen U, Ahern TP, Lash TL, Christiansen P, Ejlertsen B, Sørensen HT.  Low-dose aspirin, non-steroidal anti-inflammatory drugs, selective COX-2 inhibitors and breast cancer recurrence.  Epidemiology.  2016 Mar 22.  [Epub ahead of print].  PMID: 27007644

Borgquist S, Tamimi RM, Chen WY, Garber JE, Eliassen AH, Ahern TP.  Statin Use and Breast Cancer Risk in the Nurses' Health Study.  Cancer Epidemiol Biomarkers Prev.  2016 Jan;25(1):201-6.  doi: 10.1158/1055-9965.EPI-15-0654.  PMID: 26762806.  PMCID: PMC4842011.  [Available on 2017-01-01]

Ahern TP, Horváth-Puhó E, Spindler KL, Sørensen HT, Ording AG, Erichsen R.  Colorectal cancer, comorbidity, and risk of venous thromboembolism: assessment of biological interactions in a Danish nationwide cohort.  Br J Cancer.  2016 Jan 12;114(1):96-102.  doi: 10.1038/bjc.2015.406. Epub 2015 Dec 1.  PMID: 26625005.  PMCID: PMC4716535.  [Available on 2017-01-12]

Cronin-Fenton DP, Heide-Jørgensen U, Ahern TP, et al.  Opioids and breast cancer recurrence: A Danish population-based cohort study.  Cancer.  2015 Oct 1;121(19):3507-14.  doi: 10.1002/cncr.29532.  Epub 2015 Jul 24.  PMID: 26207518.  PMCID: PMC4575607.  [Available on 2016-10-01]


To view more publications, go to Pubmed